Track USANA Health Sciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

USANA Health Sciences, Inc. USNA · Stock Open USANA Health Sciences, Inc. in new tab

14.14 USD
Add to portfolio
P/E
31.17
EPS
-1.15
P/B
0.52
ROE
-5.06
Beta
0.68
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateOct. 28, 2026
P/E31.17
EPS-1.15
Book Value28.51
Price to Book0.52
% Insiders40.885%
Growth
Revenue Growth-0.05%
Estimates
Forward P/E8.42
Forward EPS1.77

DCF Valuation

Tweak assumptions to recompute fair value for USANA Health Sciences, Inc. (USNA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

USANA Health Sciences, Inc. Logo USANA Health Sciences, Inc. Analysis (USNA)

United States Consumer Staples Official Website Stock

Is USANA Health Sciences, Inc. a good investment? USANA Health Sciences, Inc. (USNA) is currently trading at 14.14 USD.

In terms of valuation, the stock trades at a P/E ratio of 31.17. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: USANA Health Sciences, Inc. is expected to release its next earnings report on Oct. 28, 2026. The market consensus estimate for Forward EPS is 1.77.

Investor FAQ

Does USANA Health Sciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is USANA Health Sciences, Inc.?

USANA Health Sciences, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Oct. 28, 2026. The company currently has a trailing EPS of -1.15.

Company Profile

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Exchange Ticker
NYQ (United States) USNA
FRA (Germany) USJ.F
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Aug. 4, 1998 2:1
Oct. 31, 2003 2:1
Nov. 23, 2016 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion